Clinical Trials in Phoenix

Showing 10801-10820 of 14,291 trials

Idarubicin and High-Dose Cytarabine in Treating Patients With Acute Myeloid Leukemia

NCT00528398

RATIONALE: Drugs used in chemotherapy, such as idarubicin and cytarabine, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more cancer cells. PURPOSE: This phase II trial is studying how well giving idarubicin together with high-dose cytarabine works in treating patients with acute myeloid leukemia.

Leukemia

City of Hope Medical Center111 participantsStarted Sep 1994

Phoenix, Arizona, United States • Duarte, California, United States

COMPLETEDPhase 29.0 miles

PT003 MDI Cardiovascular Safety Study

NCT01349803

This study is primarily a safety study. The primary and secondary endpoints are based on 24-hour Holter monitor assessments obtained on Day 14 relative to baseline.

Chronic Obstructive Pulmonary Disease

Pearl Therapeutics, Inc.237 participantsStarted May 2011

Glendale, Arizona, United States • Fullerton, California, United States • Los Angeles, California, United States +17 more locations

Idarubicin and High-Dose Cytarabine in Treating Patients With Acute Myeloid Leukemia

PT003 MDI Cardiovascular Safety Study

Find Trials by Condition in Phoenix

A Study of Belimumab in Subjects With Systemic Lupus Erythematosus

ProMRI Study of the Entovis Pacemaker System

Safety and Efficacy of SNX-5422 in Human Epidermal Growth Factor Receptor 2 (HER2) Positive Cancers

Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia

Natural History Study of Infants With Adrenal Masses Found on Prenatal and/or Neonatal Imaging

Safety and Efficacy of Fibrin Sealant Grifols (FS Grifols) During Parenchymous Tissue Open Surgeries

The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients

Paired-Comparison Study Evaluating the Efficacy and Safety of E6201 Versus Vehicle for the Treatment of Plaque-Type Psoriasis

A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease to Evaluate Once Daily Versus Twice Daily Dosing (EDGE)

A Phase 1/2 Study of High-dose Genetically Targeted Enzyme Replacement Therapy for Advanced Heart Failure

Comparison of Intranasal Kovacaine Mist, and Placebo for Anesthetizing Maxillary Teeth in Adults

A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 2 of 2)

Lume Lung 2 : BIBF 1120 Plus Pemetrexed Compared to Placebo Plus Pemetrexed in 2nd Line Nonsquamous NSCLC

Managing Wounds With Allevyn Life in a Home Health Care Environment

A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 1 of 2)

A Phase 2 Study With MIP-1404 in Men With High-Risk PC Scheduled for RP and EPLND Compared to Histopathology

Surgical Ablation Versus No Surgical Ablation for Patients With Atrial Fibrillation Undergoing Mitral Valve Surgery

A Study of LY2940094 in Participants With Alcohol Dependency